<- Go Home
CellMetrix, Inc.
CellMetrix, Inc. operates as medical technology company that develops clinical testing applications and automated laboratory systems that together allow for the early detection, diagnosis, characterization, treatment, and monitoring of significant human diseases. The company currently is focused on developing clinical testing applications for lung cancer and has already fully developed and begun marketing its first clinical application called LungCheck to targeted healthcare providers.
Market Cap
$21.9K
Volume
25.6K
Cash and Equivalents
$9.0K
EBITDA
-$3.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$42.0K
Profit Margin
82.35%
52 Week High
$0.00
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.03
Price / Earnings
-0.00
Price / Tangible Book Value
-0.01
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$4.0M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$9.0K
Debt
$1.2M
Equity
$866.0K
Revenue
$51.0K
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium